There is limited literature on the implications of GLP-1 RAs in the field of otolaryngology
Exclusion criteria included: type 1 diabetes, either acute or chronic pancreatitis, proliferative diabetic retinopathy or macular diabetes, non-proliferative diabetic retinopathy requiring urgent treatment, either acute or chronic hepatopathy with clinic or laboratory evidence of liver injury (e.g., 3-fold elevation in plasmatic transaminases), severe hypoglycemia or unawareness hypoglycemia, gastroparesis, previous bariatric surgery, concomitant use of certain medications delaying gastric emptying, established coronary disease or severe chronic heart failure (NYHA class III or IV), glomerular filtration rate 50%
Carbamidomethylation of cysteine residues was designated as a fixed modification
Such conditions develop gradually, and early intervention with FDA-approved medications can significantly reduce these risks
Over the past year, youll have noticed GLP-1 popping up in headlines, social media posts and conversations about weight loss
